Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yonghui Chen

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
The Journal of Urology|February 25, 2025
A Phase 2 Study of Tislelizumab as Neoadjuvant Treatment of Cisplatin-Ineligible High-Risk Upper Tract Urothelial CarcinomaJiwei Huang, Xingyun Cai, Cheoklong Ng, et al.
Journal of Extracellular Vesicles|February 9, 2026
Tissue-Derived Extracellular Vesicles Define Diagnostic Biomarkers for Renal Cell CarcinomaXinrui Wu, Jiale Zhou, Chen Jiang, et al.
Toxicology|April 6, 2025
MLKL triggers NLRP3 activation in sodium arsenite-induced myocardial necroinflammationYixin Cui, Meng Zhang, Yi Xiao, et al.
World Journal of Orthopedics|May 8, 2023
Acute hospital-community hospital care bundle for elderly orthopedic surgery patients: A propensity score-matched economic analysisIvan En-Howe Tan, Aik Yong Chok, Yun Zhao, et al.
Journal for Immunotherapy of Cancer|June 11, 2024
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trialJiwei Huang, Yueming Wang, Fan Xu, et al.
The Journal of Urology|October 4, 2022
Robotic Level IV Inferior Vena Cava Thrombectomy Using an Intrapericardial Control Technique: Is It Safe Without Cardiopulmonary Bypass?Qingbo Huang, Guodong Zhao, Yonghui Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 8, 2024
Serum and Urine Metabolic Fingerprints Characterize Renal Cell Carcinoma for Classification, Early Diagnosis, and PrognosisXiaoyu Xu, Yuzheng Fang, Qirui Wang, et al.
Cancer Medicine|September 16, 2024
Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective studyRuopeng Su, Tingxuan Huang, Liangyou Gu, et al.
NPJ Digital Medicine|November 17, 2025
A multimodal AI model for precision prognosis in clear cell renal cell carcinoma: A multicenter studyXinyi Zang, Yujia Xia, Haibing Xiao, et al.
Clinical Genitourinary Cancer|May 10, 2025
Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell CarcinomaCheoklong Ng, Cheng Peng, Shangqian Wang, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
The Journal of Urology|February 25, 2025
A Phase 2 Study of Tislelizumab as Neoadjuvant Treatment of Cisplatin-Ineligible High-Risk Upper Tract Urothelial CarcinomaJiwei Huang, Xingyun Cai, Cheoklong Ng, et al.
Journal of Extracellular Vesicles|February 9, 2026
Tissue-Derived Extracellular Vesicles Define Diagnostic Biomarkers for Renal Cell CarcinomaXinrui Wu, Jiale Zhou, Chen Jiang, et al.
Toxicology|April 6, 2025
MLKL triggers NLRP3 activation in sodium arsenite-induced myocardial necroinflammationYixin Cui, Meng Zhang, Yi Xiao, et al.
World Journal of Orthopedics|May 8, 2023
Acute hospital-community hospital care bundle for elderly orthopedic surgery patients: A propensity score-matched economic analysisIvan En-Howe Tan, Aik Yong Chok, Yun Zhao, et al.
Journal for Immunotherapy of Cancer|June 11, 2024
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trialJiwei Huang, Yueming Wang, Fan Xu, et al.
The Journal of Urology|October 4, 2022
Robotic Level IV Inferior Vena Cava Thrombectomy Using an Intrapericardial Control Technique: Is It Safe Without Cardiopulmonary Bypass?Qingbo Huang, Guodong Zhao, Yonghui Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 8, 2024
Serum and Urine Metabolic Fingerprints Characterize Renal Cell Carcinoma for Classification, Early Diagnosis, and PrognosisXiaoyu Xu, Yuzheng Fang, Qirui Wang, et al.
Cancer Medicine|September 16, 2024
Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective studyRuopeng Su, Tingxuan Huang, Liangyou Gu, et al.
NPJ Digital Medicine|November 17, 2025
A multimodal AI model for precision prognosis in clear cell renal cell carcinoma: A multicenter studyXinyi Zang, Yujia Xia, Haibing Xiao, et al.
Clinical Genitourinary Cancer|May 10, 2025
Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell CarcinomaCheoklong Ng, Cheng Peng, Shangqian Wang, et al.
Pageof 18